Here, we report that it’s feasible to image gastric adenocarcinoma with prostate-specific membrane antigen (PSMA) targeting imaging agents, which could potentially provide an alternate and readily translational tool for managing gastric cancer. This evidence concerns the gene FOLH1 and gastric adenocarcinoma.